Elective Percutaneous Coronary Intervention in Ambulatory Surgery Centers

被引:6
|
作者
Li, Kevin [1 ]
Kalwani, Neil M. [2 ]
Heidenreich, Paul A. [2 ]
Fearon, William F. [2 ]
机构
[1] Stanford Univ, Dept Med, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Med, Stanford Cardiovasc Inst, Div Cardiovasc Med, 300 Pasteur Dr,H2103, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
ischemic heart disease; outcomes; PCI; percutaneous coronary intervention; health services research; SAME-DAY DISCHARGE; TEMPORAL TRENDS; ANGIOGRAPHY; MORTALITY; OUTCOMES; ACCESS; IMPACT; RISK; SITE;
D O I
10.1016/j.jcin.2020.10.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The aim of this study was to explore characteristics and outcomes of patients undergoing elective percutaneous coronary intervention (PCI) in ambulatory surgery centers (ASCs). BACKGROUND Little is known about patients who underwent ASC PCI before Medicare reimbursement was instituted in 2020. METHODS Using commercial insurance claims from MarketScan, adults who underwent hospital outpatient department (HOPD) or ASC PCI for stable ischemic heart disease from 2007 to 2016 were studied. Propensity score analysis was used to measure the association between treatment setting and the primary composite outcome of 30-day myocardial infarction, bleeding complications, and hospital admission. RESULTS The unmatched sample consisted of 95,492 HOPD and 849 ASC PCIs. Patients who underwent ASC PCI were more likely to be younger than 65 years, to live in the southern United States, and to have managed or consumer-driven health insurance. ASC PCI was also associated with decreased fractional flow reserve utilization (odds ratio [OR]: 0.31; 95% confidence interval [CI]: 0.20 to 0.48; p < 0.001). In unmatched, multivariate analysis, ASC PCI was associated with increased odds of the primary outcome (OR: 1.25; 95% CI: 1.01 to 1.56; p = 0.039) and bleeding complications (OR: 1.80; 95% CI: 1.11 to 2.90; p = 0.016). In propensity-matched analysis, ASC PCI was not associated with the primary outcome (OR: 1.23; 95% CI: 0.94 to 1.60; p = 0.124) but was significantly associated with increased bleeding complications (OR: 2.49; 95% CI: 1.25 to 4.95; p = 0.009). CONCLUSIONS Commercially insured patients undergoing ASC PCI were less likely to undergo fractional flow reserve testing and had higher odds of bleeding complications than HOPD-treated patients. Further study is warranted as Medicare ASC PCI volume increases. (J Am Coll Cardiol Intv 2021;14:292-300) Published by Elsevier on behalf of the American College of Cardiology Foundation
引用
收藏
页码:292 / 300
页数:9
相关论文
共 50 条
  • [1] Elective Percutaneous Coronary Intervention in Ambulatory Surgery Centers Is This a Bridge Too Far?
    Dehmer, Gregory J.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (03) : 301 - 303
  • [2] Percutaneous Coronary Intervention in Ambulatory Surgery Centers: Is It Safe?
    Li, Kevin
    Kalwani, Neil M.
    Heidenreich, Paul A.
    Fearon, William F.
    CIRCULATION, 2020, 142
  • [3] SCAIposition statement on the performance of percutaneous coronary intervention in ambulatory surgical centers
    Box, Lyndon C.
    Blankenship, James C.
    Henry, Timothy D.
    Messenger, John C.
    Cigarroa, Joaquin E.
    Moussa, Issam D.
    Snyder, Richard W.
    Duffy, Peter L.
    Carr, Jeffrey G.
    Tukaye, Deepali N.
    Ang, Lawrence
    Shah, Binita
    Rao, Sunil, V
    Mahmud, Ehtisham
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 96 (04) : 862 - 870
  • [4] Elective percutaneous coronary intervention is safe without onsite surgery
    Menon, Pramod V.
    Stoner, Casey N.
    House, John A.
    Safley, David M.
    Barberena, Jaime E.
    Grantham, J. Aaron
    Marso, Steven P.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 193M - 193M
  • [5] Overlap in Age at the Time of Elective Percutaneous Coronary Intervention and at Noncardiac Surgery
    Smilowitz, Nathaniel R.
    Berger, Jeffrey S.
    Beckman, Joshua A.
    Bangalore, Sripal
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : 1554 - 1555
  • [6] Enoxaparin in elective percutaneous coronary intervention
    Bhala, Neeraj
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (26): : 2788 - 2788
  • [7] Elective percutaneous coronary intervention complicated by coronary rupture
    Braga, Carlos Galvao
    Martins, Juliana
    Arantes, Carina
    Abreu, Gloria
    Costa, Joao
    Marques, Jorge
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2015, 34 (03) : 215 - 216
  • [8] Clopidogrel Before Elective Percutaneous Coronary Intervention
    Motovska, Zuzana
    Widimsky, Petr
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (04): : 373 - 379
  • [9] The Impact of Elective Percutaneous Coronary Intervention on Coronary Microvascular Resistance
    Murai, Tadashi
    Lee, Tetsumin
    Suzuki, Asami
    Kanaji, Yoshihisa
    Matsuda, Junji
    Araki, Makoto
    Nlida, Takayuki
    Isobe, Mitsuaki
    Kakuta, Tsunekazu
    CIRCULATION, 2014, 130
  • [10] The impact of elective percutaneous coronary intervention on coronary microvascular resistance
    Murai, T.
    Lee, T.
    Kanaji, Y.
    Matsuda, J.
    Usui, E.
    Araki, M.
    Niida, T.
    Isobe, M.
    Kakuta, T.
    EUROPEAN HEART JOURNAL, 2015, 36 : 298 - 298